NCT06483854 Healer-initiated HIV Counseling and Testing Versus Standard of Care in Rural South Africa
| NCT ID | NCT06483854 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vanderbilt University Medical Center |
| Condition | Hiv |
| Study Type | INTERVENTIONAL |
| Enrollment | 230,907 participants |
| Start Date | 2024-11-25 |
| Primary Completion | 2028-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 230,907 participants in total. It began in 2024-11-25 with a primary completion date of 2028-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
South Africa has made progress towards their 95-95-95 goals, yet a substantial proportion of the population do not test regularly. To reach people who otherwise may avoid testing, we propose to build on our successful healer-initiated HIV counseling and testing pilot to conduct a cluster randomized controlled trial in 42 clinical catchment areas to evaluate an expanded Healer-Initiated HIV Testing and Linkage to Care intervention in rural South Africa.
Eligibility Criteria
Inclusion Criteria: * Community members \> 18 years of age, who chose to receive an HIV test from a traditional healer. Exclusion Criteria: * Community members who are not of sound mind or body during the recruitment (inebriated, experiencing a mental health issue).
Contact & Investigator
Carolyn Audet, PhD
PRINCIPAL INVESTIGATOR
Vanderbilt University
Frequently Asked Questions
Who can join the NCT06483854 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hiv. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06483854 currently recruiting?
Yes, NCT06483854 is actively recruiting participants. Contact the research team at carolyn.m.audet@vumc.org for enrollment information.
Where is the NCT06483854 trial being conducted?
This trial is being conducted at Agincourt, South Africa.
Who is sponsoring the NCT06483854 clinical trial?
NCT06483854 is sponsored by Vanderbilt University Medical Center. The principal investigator is Carolyn Audet, PhD at Vanderbilt University. The trial plans to enroll 230,907 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.